{
  "retracted": false,
  "timestamp": 1584662400000,
  "updates": [
    {
      "timestamp": 1591768615088,
      "identifier": {
        "doi": "10.1182/bloodadvances.2020001818"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1182/bloodadvances.2019001148"
  },
  "journal": "Blood Advances",
  "publisher": "American Society of Hematology",
  "title": "Carden MA, Gaddh M, Hoskote A, et al. Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020;4(3):477-481."
}
